These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 8018034)
1. Transient improvement in Guillain-Barré syndrome after megadose intravenous methylprednisolone. Bethea JW; Hogan EL Arch Neurol; 1994 Jul; 51(7):644-5. PubMed ID: 8018034 [No Abstract] [Full Text] [Related]
2. Ineffectiveness of high-dose intravenous methylprednisolone in Guillain-Barré syndrome. Hughes RA Lancet; 1991 Nov; 338(8775):1142. PubMed ID: 1682558 [No Abstract] [Full Text] [Related]
3. Treatment of Guillain-Barré syndrome with intravenous methylprednisolone. Hughes R; Swan A Ann Neurol; 1995 May; 37(5):683-4. PubMed ID: 7755366 [No Abstract] [Full Text] [Related]
4. Failure of oral versus parenteral corticosteroids in a case of acute inflammatory polyradiculoneuropathy (Guillain-Barré syndrome). Brumback RA Aust N Z J Med; 1980 Apr; 10(2):224-6. PubMed ID: 6930216 [TBL] [Abstract][Full Text] [Related]
5. [Immunoglobulins and corticoids in Guillain-Barre syndrome: a report of a new case. Letter]. Riol Diego M; Jiménez Monteagudo M; López de Mesa R; Alzina de Aguilar V An Esp Pediatr; 1996 Nov; 45(5):547-9. PubMed ID: 9036793 [No Abstract] [Full Text] [Related]
8. Rapid recovery of a child with Guillain-Barré syndrome using intravenous immunoglobulins. Shah M; Weinberger M J La State Med Soc; 1998 Nov; 150(11):533-7. PubMed ID: 9861805 [TBL] [Abstract][Full Text] [Related]
10. [Beneficial effects of plasma exchange in acute Guillain-Barré syndrome: comparison with methylprednisolone pulse therapy]. Mori E; Yoshida T; Ohsumi Y; Tabuchi M; Yamadori A Rinsho Shinkeigaku; 1988 Feb; 28(2):196-203. PubMed ID: 3409619 [No Abstract] [Full Text] [Related]
11. [A case of Guillain-Barré syndrome treated with intravenous high doses of immunoglobulins]. Mauro G Rev Neurol (Paris); 1989; 145(10):731-2. PubMed ID: 2510231 [TBL] [Abstract][Full Text] [Related]
12. Treatment of Guillain-Barré syndrome with high-dose immune globulins combined with methylprednisolone: a pilot study. The Dutch Guillain-Barré Study Group. Ann Neurol; 1994 Jun; 35(6):749-52. PubMed ID: 8210234 [TBL] [Abstract][Full Text] [Related]
13. Risk factors for treatment related clinical fluctuations in Guillain-Barré syndrome. Dutch Guillain-Barré study group. Visser LH; van der Meché FG; Meulstee J; van Doorn PA J Neurol Neurosurg Psychiatry; 1998 Feb; 64(2):242-4. PubMed ID: 9489539 [TBL] [Abstract][Full Text] [Related]
14. The Guillain-Barre syndrome following gold therapy. Dick DJ; Raman D Scand J Rheumatol; 1982; 11(2):119-20. PubMed ID: 7089501 [No Abstract] [Full Text] [Related]
18. Campylobacter jejuni bacteremia and Guillain-Barré syndrome in a patient with GVHD after allogeneic BMT. Hagensee ME; Benyunes M; Miller JA; Spach DH Bone Marrow Transplant; 1994 Mar; 13(3):349-51. PubMed ID: 8199580 [TBL] [Abstract][Full Text] [Related]
19. Severe Guillain-Barré syndrome in aged patients: the effect of plasmapheresis. Yamashita S; Morinaga T; Matsumoto K; Sakamoto T; Kaku N; Matsukura S Intern Med; 1992 Nov; 31(11):1313-6. PubMed ID: 1295631 [TBL] [Abstract][Full Text] [Related]
20. 'Intravenous immunoglobulin treatment in childhood Guillain-Barré syndrome'. Manonmani V; Ouvrier R Dev Med Child Neurol; 1997 Jun; 39(6):425. PubMed ID: 9233371 [No Abstract] [Full Text] [Related] [Next] [New Search]